This protocol describes a fluorescence birthdating technique to label, track and isolate isochronic cohorts of newborn cells in the central nervous system in vivo. Injection of carboxyfluorescein esters into the cerebral ventricle allows pulse-labeling of M-phase progenitors in touch with the ventricle and their progeny across the central nervous system, a procedure we termed FlashTag. Labeled cells can be imaged ex vivo or in fixed tissue, targeted for electrophysiological experiments, or isolated using Fluorescence-Activated Cell Sorting (FACS) for cell culture or (single-cell) RNA-sequencing. The dye is retained for several weeks, allowing labeled cells to be identified postnatally. This protocol describes the labeling procedure using in utero injection, the isolation of live cells using FACS, as well as the processing of labeled tissue using immunohistochemistry. take advantage of the juxtaventricular location of M-phase progenitors to pulse-label them by intraventricular injection of a carboxyfluorescein ester (a procedure we termed "FlashTag", FT). This procedure allows fluorescent tagging of VZ progenitors and tracking of time-locked cohorts of their postmitotic progeny, including neurons, throughout corticogenesis and early postnatal development.
INTRODUCTION
The ability to track neurons from their time of birth until adulthood is crucial to resolve neuronal lineages and investigate the developmental mechanisms underlying neuronal diversity. Neurons in the central nervous system (CNS) are born within two germinal zones, a ventricular zone (VZ), which is located adjacent to the ventricular wall and contains radial glia, and, in many brain regions, a subventricular zone (SVZ), which is located more basally and contains intermediate progenitors 1 . Within the VZ, and across the CNS, radial glial cells undergo interkinetic migration 1 , such that their soma is at a different location at different phases of the cell cycle: S-phase occurs at the basal-most border of the VZ, while M-phase (cell division) occurs at the ventricular wall, in contact with the ventricular cavity, which is thus where neurons are born (Fig 1a) . In the present protocol, we describe a procedure in which we cells in the embryo, with no spatial restriction, such that in the CNS, both VZ and SVZ-born neurons are labeled. Of note, the term "birthdating" is somewhat of a misnomer, because BrdUlabeled daughter neurons are not neurons which were born at the time of injection (which would be the case upon M-phase labeling, as occurs with FT), but instead are the progeny of cells which were undergoing S-phase at the time of labeling. Following i.p. injection in pregnant mice, BrdU labeling is detected within 30 minutes, and dividing cells incorporate BrdU during a time window of approximately 2-6 hours 2, 4 . In order to reveal BrdU labeling, tissue fixation and an aggressive DNA denaturation protocol is required 3 , such that BrdU birthdating cannot be combined with applications in which live cells need to be isolated or analysed, including live imaging, electrophysiology or transcriptomics. Other thymidine analogues, such as 5ethynyl-2-deoxyuridine (EdU), 5-chloro-2'-deoxyuridine (CldU) and 5-iodo-2'-deoxyuridine (IdU) exist, which can be used for combinatorial labeling of cells born at different times, but which suffer from the same limitations 5 . Finally, it is important to note that BrdU is also incorporated during nucleotide replacement during DNA repair 6 (which occurs during early neuron differentiation 7, 8 ) such that it is not an entirely specific marker of S phase. Results of BrdU experiments should thus be examined with caution depending on context.
Another second birthdating technique that partially overcomes the limitations of BrdU is viral labeling. This approach relies on the use of a replication-deficient virus (typically a retrovirus) expressing a reporter protein 9 . The virus is injected into the cerebral ventricles of developing embryos, from where it infects cells that are located at the ventricular border. Upon infection, the virus integrates into the genome and initiates expression of a reporter protein.
While this approach is applicable to in and ex vivo applications, such as live imaging, and infection is limited to a specific cohort of cells (even allowing clonal analysis when very low titers of viruses are used, see ref. 10 ), a major limitation is that it takes a considerable amount of time until the fluorescent reporter is expressed (usually about a day or more in the mouse 11 ), such that the precise time of birth of the labeled neurons is difficult to determine without using additional approaches (such as BrdU birthdating). This limitation makes it difficult to use viral labeling to analyse cells immediately after their birth 9, 12 .
A third commonly used approach to label newborn cells in the developing brain is in utero electroporation. In this procedure, a plasmid coding for a reporter protein is injected into the ventricle and electrical pulses are applied to enable entry of the plasmid into cells. Plasmid transfer is most efficient in M-phase cells, but also affects S-phase cells and is not restricted to the ventricular border 13, 14 (see in particular Supplementary Fig.1 in ref.14 in which a BrdUlabeled plasmid was used to identify cells exposed to the plasmid immediately after electroporation, revealing that all VZ and SVZ cells are exposed). Thus, a broad range of unsynchronized progenitors is labeled, which makes analysis of the progeny complex, in terms of developmental trajectories and lineage relationships. Another limitation of in utero electroporation is that detection of labeled cells is possible only after expression of the reporter protein (typically around 10 hours in the mouse 14 ), making it difficult to study events occurring upon or immediately following cell division.
To circumvent the limitations of the birthdating techniques described above, we recently developed FT to birthdate, track and isolate isochronic cohorts of VZ-born cells in the developing central nervous system 7 . This technique takes advantage of the fact that VZ progenitors divide exclusively at the ventricular wall, where they can be specifically labeled, and allows labeling a spatially defined cohort (cells in the VZ across the CNS) of cell cycle phase-locked cells (M-phase) with a high temporal resolution ( Fig 1) : an intracellular fluorescent signal is detected within 20 minutes. Furthermore, at least in the neocortex, labeling is restricted to 1-2 hours (i.e. approximately 1-2 round of mitosis) which follow injection ( Fig   1c) . The fluorescence signal can be detected without immunohistochemistry, allowing FT to be used for ex vivo (and, in principle, in vivo) live imaging and electrophysiology, as well as to isolate progenitors and neurons for cell culture or bulk / single-cell RNA sequencing.
FT principle and direct comparison with BrdU and in utero electroporation
Here, we will briefly review the use of FT for neuronal birthdating and compare it to other existing strategies (see Table 1 and Box 1). To perform FlashTag, carboxyfluorescein diacetate succinimidyl ester (CFSE) is injected into the ventricular system, resulting in the specific labeling of mitotic cells at the ventricular border, which are in contact with the cerebrospinal fluid ( Fig 1a) . CFSE is colourless when it is extracellular and becomes fluorescent only after being enzymatically processed inside the cell (see Box 1 for details), such that 20 minutes after injection, high intracellular fluorescence is observed along the entire ventricular walls (Fig 1b) . Once inside the cell, FT is diluted at each cell division, such that FT intensity can in principle be used to determine the number of cell divisions that have occurred between labeling and collection. This principle has long been applied in the hematopoietic system 15 , and can, to a certain extent, be applied in the CNS to distinguish neurons born directly from the VZ from those born indirectly via intermediate progenitors in the SVZ 7 . We established this principle in the neocortex using chronic IP BrdU perfusion from the time of FT injection to label all cells that entered S-phase at any time point after FT labeling (Fig 2a, b) . When examined at P7, only 10% of the brightest FT + cells were also BrdU + , indicating that the brightest FT + cells are overwhelmingly born from VZ progenitors at the time of labeling (Fig 2c) .
To directly compare FT birthdating with BrdU birthdating, we pulse-injected BrdU at the time of FT labeling. While a broad set of S-phase progenitors in the cortical VZ and SVZ is labeled by BrdU, FT specifically labels M-phase cells at the ventricular border, such that these two markers label essentially mutually exclusive populations of cells (Fig 3a) . When BrdU-labeled plasmids 14 . In contrast, FT + cells labeled at the same time were visible as a synchronized cohort, with strongly-labeled FT + cells at the SVZ/IZ border and more weaklylabeled FT + cells (most probably recycling progenitors) in the VZ (Fig 3c) .
Potential further applications of FlashTag
Although within the CNS FT has been best characterized in the neocortex of the mouse, it can be applied to other brain regions and, in principle, can be used to birthdate and isolate any type of neuron that is born in contact with the ventricular space (or, potentially, any other cavity with fluid turn-over, such as the eye) throughout the brain and spinal cord, including in adult neurogenesis, across species, and in organoid preparations 18 . In addition, FT can also be used to label cells that migrate long distances from their place of birth, such as neurons of the olfactory bulb (Fig 4) , and CFSE has been used to tag cells migrating through a given region by intraparenchymal injection 19 . The main limitations to this broad potential is the need to calibrate the half-life of FT in each condition, since temporal precision in tagging will depend on factors such as cerebrospinal flow rate, VZ permeability, and VZ progenitor kinetics.
Finally, since fluorescence distributes into the cytoplasm, FT allows visualising the morphology of labeled cells, including, in some instances, projections (e.g. axons but also basal processes in radial glia).
Interestingly, by allowing the temporally precise labeling of sequentially-born neuronal populations, FT could be used as a template to establish correspondences between equivalent populations of cells across distantly-related species (e.g. mammals vs. sauropsids) without the need for potentially arbitrary molecular markers. By allowing isolation of isochronic neurons at precise sequential developmental stages, FT can also be used to directly characterise the transcriptional progression of cell populations over time and be used to validate or refine bioinformatics pseudotime alignment approaches 7, 18 .
Finally, FT can be combined with other techniques, such as in utero electroporation, to specifically assess the effect of gene manipulation on a temporally restricted cohort of cells, as we have done in the past 7 . Of note, if combining FT with in utero electroporation, in the neocortex, on embryonic day 14.5, FT should be performed 4 -6 h after electroporation to ensure double labeling. This interval corresponds to the time that electroporated cells need to reach the ventricular border (i.e. the S-to-M duration), and thus to be able to be labeled by FT.
Importantly, the electroporation-to-FT delay should be calibrated for each structure and developmental stage to allow for optimal co-labeling.
Limitations of FlashTag
• In the neocortex, FT signal is retained up until the third postnatal week. Over time, labeling becomes less bright, most probably due to protein turnover. However, when using CFSE, it is possible to enhance signal through immunohistochemistry using an anti-FITC antibody (see procedure and Fig. 6 ).
• FT signal intensity largely depends on the injection site: injection in the lateral ventricle will result in strong labeling in the forebrain but in a weaker signal in the mid-and hindbrain, while the converse is true for third ventricle injections. Thus, comparison of FT cell intensity across different brain regions (including across hemispheres) requires careful optimisation of injection site and volume, and calibration with chronic BrdU perfusion when focusing on direct neurogenesis from the VZ (see below). If comparing both cortices injection in the third ventricle is suggested to ensure equal labeling intensity in both hemispheres.
• When examining brains at early time points after FT labeling (e.g. 1 h), weak fluorescence can be observed in cells that were labeled by diffusion of CFSE into the VZ. A maximum intensity threshold can be applied to increase the signal to noise ratio in this case (Fig 6 A) .
• Care should be taken when analysing cells close to the injection site, as contamination with unspecific labeling can occur along the needle tract.
• When examining labeled cells in the neocortex at P7, the top 10% brightest cells essentially correspond to cells that were directly born from the VZ at the time of FT labeling (i.e. only 10% of those are co-labeled by chronic BrdU perfusion, see Fig 2) . As mentioned above, it is necessary to confirm this threshold in every examined brain structure and developmental stage by combining FT with chronic BrdU or EdU perfusion which, in our hands, is most reliably performed by using an intraperitoneally-implanted Alzet pump (see ref. 7, 20 ) . In addition, it should be noted that even when using chronic BrdU labeling, false positives are possible in the FT + BrdU + cells (i.e. these cells might wrongly be assumed to be born indirectly from the labeled progenitor yet be directly-born from a recycling progenitor at a later developmental stage).
• FT signal bleaches very fast, and thus the use of a spinning disk confocal is required when performing live imaging of FT labeled cells. Furthermore, it should be noted that when using FT to isolate cells for cell culture, the signal disappears substantially faster than in vivo.
MATERIALS

REAGENTS
induction is skipped, release will be not stable over the first 4 hours. If chronic perfusion is required for more than 72 h, a new pump needs to be added 72 h after perfusion start to replace the previous one. 25| Melt the 4% agarose and let cool down to 42 °C while proceeding to the next step.
Pipette preparation
26| Screen the heads for FT signal using appropriate fluorescence filters and dissect FT + brains (Fig 5a, b) . CRITICAL STEP Keep the brains in HBSS on ice whenever possible to minimise cell death.
27| Embed the brains in 42°C agarose using plastic moulds placed on ice.
28| Once the agarose solidifies, carefully remove agar block from plastic mould. Using a blade, remove excess agarose and cut small blocks leaving no more than 3 mm of agarose around the brain.
29| Glue the agarose blocks containing the tissue to the vibrating microtome support and cut 300 -600 µM thick coronal sections with low speed and vibration. Collect slices in a petri dish with ice-cold HBSS using an embryo spoon.
30|
With the help of a stereomicroscope, dissect the regions of interest using micro-knives and transfer the dissected part to a 1.5 ml micro-centrifuge tube placed on ice with a plastic pipette. CRITICAL STEP Keep the tissue in HBSS on ice whenever possible to minimise cell death.
31|
Remove HBSS from the tube containing tissue pieces, leaving not more than 100 µl, and add 400 µl of 1x TrypLE. Incubate for 3 -5 min at 37 °C in a water bath.
32| Add 200 µl of FBS to inactivate the TrypLE. Centrifuge at 300 g for 5 min at room temperature, remove supernatant, add 500 µl of medium, triturate the tissue manually to make a homogenous single-cell suspension. (Fig. 5c ). 48| Adjust contrast during image post processing to highlight the top 50% brightest to identify the high FT + population (i.e, the cells that were labeled by mitotic uptake of FT and that did not undergo subsequent cell division).
Immunohistochemistry of FT labeled brains • TIMING 3 days
• TIMING
Steps 1-2, surgery preparation: 10 min Steps 37 -40, vibratome sectioning and incubation with primary antibody, 1 day
Steps 41 -48, incubation with secondary antibody and imaging, 1 day
ANTICIPATED RESULTS
Cells born in the ventricular zone across the CNS can be easily followed from birth until at least 3 weeks postnatally. Examples of typical FT labeling are presented in Figure 3 (neocortex)
and Figure 4 (olfactory bulb). Labeled cells can be isolated with FACS for various applications, including single-cell RNA sequencing, or live tissue can be collected for live imaging or electrophysiology. A maximum intensity threshold can be used to strongly enrich in cells that were directly born from the VZ at the time of FT labeling, both when isolating cells using FACS, as well as when analysing labeled cells with histology.
BOX 1 | Mode of action of CarboxyFluorescein Diacetate Succinimidyl Esters for cell labeling
Carboxyfluorescein diacetate succinimidyl ester (CFDA-SE) is a commonly used reagent for long term fluorescent labeling of cells and flow cytometry-based proliferation studies 16, 17 . It is a non-fluorescent molecule, which is highly membrane permeant due to its acetate groups. across the VZ and SVZ (see e.g. Supplementary Fig. 1 in ref. 14) . 
